CDC’s COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions

Soeters, Heidi M.; Doshi, Reena H.; Fleming, Monica; Adegoke, Oluwasegun Joel; Ajene, Uzoamaka; Aksnes, Brooke; Bennett, Sarah; Blau, Erin F.; Garon, Julie; Clements, Sara; Conklin, Laura; Dahlke, Melissa; Duca, Lindsey M.; Feldstein, Leora R.; Gidudu, Jane; Grant, Gavin P.; Hercules, Margaret; Igboh, Ledor S.; Ishizumi, Atsuyoshi; Jacenko, Sara; Kerr, Yinka; Konne, Nuadum M.; Kulkarni, Shibani; Kumar, Archana; Lafond, Kathryn E.; Lam, Eugene; Longley, Ashley T; McCarron, Margaret; Namageyo-Funa, Apophia; Ortiz, Nancy; Patel, Jaymin C.; Perry, Robert T.; Prybylski, Dimitri; Reddi, Prianca; Salman, Omar; Sciarratta, Courtney N.; Shragai, Talya; Siddula, Akshita; Sikare, Ester; Tchoualeu, Dieula Delissaint; Traicoff, Denise; Tuttle, Alexandra; Victory, Kerton R.; Wallace, Aaron S.; Ward, Kirsten; Wong, Man Kai Alyssa; Zhou, Weigong; Schluter, W. William; Fitter, David; Mounts, Anthony W.; Bresee, Joseph S.; Hyde, Terri B.

doi:10.3201/eid2813.212123

Cited by 4 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The pandemic also affected clinical and health services delivery. This supplement describes impacts on vaccine-preventable disease surveillance ( 25 ), expansion of COVID-19 vaccinations ( 26 ), and the effects of decreased hepatitis B immunization coverage ( 27 ). In the WHO Africa region, more than 200 Stop Transmission of Polio (STOP) Program consultants were surveyed to clarify how vaccine-preventable disease surveillance systems were disrupted during the pandemic ( 25 ).…”

Section: Clinical and Health Services Delivery And Impactmentioning

confidence: 99%

“…In the WHO Africa region, more than 200 Stop Transmission of Polio (STOP) Program consultants were surveyed to clarify how vaccine-preventable disease surveillance systems were disrupted during the pandemic ( 25 ). CDC’s COVID-19 International Vaccine Implementation and Evaluation program applied lessons learned from Ebola, influenza, and meningococcal serogroup A conjugate vaccine introductions for the delivery of COVID-19 vaccines ( 26 ). Experiences from past rubella vaccination programs ( 28 ), yellow fever and polio immunization campaigns for COVID-19 vaccine deployment and safety monitoring in Ghana ( 29 ), and the effectiveness of inactivated whole-virus COVID-19 vaccine among healthcare personnel in Peru ( 30 ) can also inform future responses.…”

Section: Clinical and Health Services Delivery And Impactmentioning

confidence: 99%

See 1 more Smart Citation

Global Responses to the COVID-19 Pandemic

Cassell¹,

Raghunathan²,

Henao³

et al. 2022

Emerg. Infect. Dis.

View full text Add to dashboard Cite

Section: Clinical and Health Services Delivery And Impactmentioning

confidence: 99%

Section: Clinical and Health Services Delivery And Impactmentioning

confidence: 99%

Global Responses to the COVID-19 Pandemic

Cassell¹,

Raghunathan²,

Henao³

et al. 2022

Emerg. Infect. Dis.

View full text Add to dashboard Cite

Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021–2023

Dahl,

Tritter,

Butryn

et al. 2024

Vaccine

View full text Add to dashboard Cite

“Implementation of intensified COVID-19 vaccination optimization (ICVOPT) campaigns strategy in complex humanitarian emergency settings and hard-to-reach areas; a case of South Sudan”

Atwongyeire,

Tegegne,

Ndenzako

et al. 2024

BMC Infect Dis

View full text Add to dashboard Cite

Introduction The COVID-19 pandemic is still a public health concern in South Sudan having caused suffering since the first case of COVID-19 was introduced on 28th February 2020. COVAX vaccines have since been introduced using a number of strategies including fixed site, temporary mobile, hit and run in flooded and conflict affected areas. We aim to describe the 2 ICVOPT campaigns that were conducted to improve the uptake and document lessons learnt during the initial rollout of the COVID-19 vaccination programin South Sudan between February 2022 and June 2022 each lasting for 7-days. Methodology We conducted an operational cross-sectional descriptive epidemiological study of a series of the intensified COVID-19 vaccination Optimization (ICVOPT) campaigns from February 2022 to June 2022. Before the campaign, a bottom up micro-planning was conducted, validated by the County Health Departments (CHDs) and national MOH team. Each of the 2 campaigns lasted for 7 days targeting 30% of the eligible unvaccinated target population who were18 years and above. Each team consisted of 2 vaccinators, 2 recorders and 1 mobilizer. The teams employed both fixed site, temporary mobile, hit and run in flooded and conflict affected areas. The number of teams were calculated based on the daily workload per day (80 persons per team/day) for the duration of the campaigns. Results A total of 444,030 individuals were vaccinated with primary series COVID-19 vaccine (J&J) out of the targeted 635,030 persons. This represented 69.9% of target population in the selected 28 counties and 10 states of South Sudan in 7 days’ ICVOPT campaigns. More eligible persons were reached in 7 days campaigns than the 9 months of rollout of the COVID-19 vaccine prior to ICVOPT campaigns using the fixed site strategy at the health facility posts. Conclusion Intensified COVID-19 vaccination Optimization (ICVOPT) campaigns were vital and fast in scaling up vaccination coverages as compared to the fixed site vaccination strategies (2022 progress report on the Global Action Plan for Healthy Lives and Well-being for All Stronger collaboration for an equitable and resilient recovery towards the health-related Sustainable Development Goals, incentivizing collaboration, 2022) in complex humanitarian emergency settings and hard-to-reach areas of South Sudan.

show abstract

CDC’s COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions

Cited by 4 publications

References 22 publications

Global Responses to the COVID-19 Pandemic

Global Responses to the COVID-19 Pandemic

Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021–2023

“Implementation of intensified COVID-19 vaccination optimization (ICVOPT) campaigns strategy in complex humanitarian emergency settings and hard-to-reach areas; a case of South Sudan”

Contact Info

Product

Resources

About